Apricus Biosciences, Inc., a biopharmaceutical company, has announced the launch of Vytaros, for treatment of erectile dysfunction, in Belgium by the Sandoz Division of the Novartis Group of Companies. Apricus' novel topical on-demand treatment for ... Individual.com, 1 month ago
Sandoz launches generic Cialis for erectile dysfunction treatment in Brazil - Individual.com, 4 days ago
Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R) - BioMedReports, 4 days ago
2 images for "sandoz inc"
Phase 3 Data Shows Sandoz, Inc.'s Investigational Biosimilar Filgrastim Has Similar Safety And Efficacy As Amgen's NEUPOGEN??
Pivotal PIONEER study compared safety and efficacy of the two compounds in the prevention of neutropenia in patients with breast cancer PIONEER data supported filing for biosimilar filgrastim in the US The abstract of the study results is ...BioSpace, 2 weeks ago Novartis AG Copy Of Amgen Cancer Drug Shows Similar Efficacy BioSpace, 2 weeks ago Novartis AG (NVS) Copy Of Amgen (AMGN) Cancer Drug Shows Similar Efficacy 12/8/2014 ClinicSpace, 2 weeks ago Novartis : Phase III data shows Sandoz' investigational biosimilar filgrastim has similar safety and efficacy as Amgen's NEUPOGEN® 4 Traders, 2 weeks ago
Sandoz Inc. has received marketing authorizations from the pharmaceutical regulatory authorities in Estonia, Latvia and Lithuania for AirFluSal Forspiro, a new inhaler for patients with asthma and/or chronic obstructive pulmonary disease, or COPD.Individual.com, 1 month ago
By Dec 5 (Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits. The ruling, handed ...Sharenet, 3 weeks ago
More from: CNBC, Reuters UK...and 7 other sources
the Supreme Court heard oral arguments in , regarding the proper standard of review for patent claim constructions. Although de novo review of district court claim constructions has been the US Court of Appeals for the Federal Circuit's modus ...Intellectual Property Magazine, 1 month ago Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc. (Fed. Cir. 2014) JD Supra, 3 weeks ago Supreme Court Corner: Q4 2014 JD Supra, 6 days ago Supreme Court 2014 Patent Preview JD Supra, 1 week ago
More from: , 4 Traders...and 1 other sources
Federal Circuit Rules Against Patent Declaratory Judgment Actions Before Biosimilar Application Is Filed
On December 5, 2014, the Federal Circuit issued its opinion in Sandoz Inc. v. Amgen Inc. et al. In a unanimous panel opinion (Judges Dyk, Taranto and Chen), the Court held that clinical trials initiated to support a possible subsequent filing of a ...JD Supra, 1 week ago Sandoz Was Disinvited to the Patent Dance: The Federal Circuit's First Interpretation of the BPCIA Will Have to Wait JD Supra, 1 week ago Celltrion Healthcare Co. v. Kennedy Trust for Rhematology Research (S.D.N.Y. 2014); Hospira Inc. v. Janssen Biotech Inc. (S.D.N.Y. 2014) JD Supra, 1 week ago Sandoz Inc. v. Amgen Inc. (Fed. Cir. 2014) JD Supra, 2 weeks ago
body: The Food and Drug Administration (FDA) plans to hold an advisory committee meeting in January 2015 on Sandoz Inc.'s proposed biosimilar version of Amgen Inc.'s Neupogen (filgrastim) (79 Fed. Reg. 73,326). In July, FDA accepted Sandoz's ...AAPS Pharmceutica, 1 week ago Amgen : Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 73326) - Meeting 4 Traders, 1 week ago Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 73326) - Meeting Pharmacy Choice, 1 week ago
TRENTON, N.J., Nov. 6 -- The New Jersey Economic Development Authority issued the following news release: Showcasing New Jersey's continued ability to retain life-science companies, Lt. Governor Kim Guadagno today joined executives from Sandoz, ...Pharmaceutical & Medical Packaging News, 1 month ago Novartis : Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters 4 Traders, 1 month ago
Sandoz Inc., the generic pharmaceutical division of Novartis, has launched the generic version of cyclophosphamide injection, USP, an anti-cancer drug in the US. Sandoz is launching cyclophosphamide injection, USP, through collaboration with Jiangsu ...Individual.com, 1 month ago
Harvard Bioscience, Inc., a manufacturer of scientific instruments and apparatus, has elected Bertrand Loy to its board of directors. Mr Loy is President and CEO of Entegris Inc., a provider of yield-enhancing materials and solutions used in ...Individual.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!